CHARLES SCHWAB INVESTMENT MANAGEMENT INC - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 75 filers reported holding KEMPHARM INC in Q3 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$435,882
-5.5%
90,4320.0%0.00%
Q2 2023$461,203
+652.8%
90,432
+711.9%
0.00%
Q1 2023$61,265
+19.8%
11,1390.0%0.00%
Q4 2022$51,128
-27.0%
11,1390.0%0.00%
Q3 2022$70,000
+40.0%
11,1390.0%0.00%
Q2 2022$50,000
-87.0%
11,139
-85.4%
0.00%
Q1 2022$384,000
-42.3%
76,2370.0%0.00%
Q4 2021$665,000
-0.7%
76,237
+6.3%
0.00%
Q3 2021$670,000
-27.2%
71,7320.0%0.00%
Q2 2021$920,00071,7320.00%
Other shareholders
KEMPHARM INC shareholders Q3 2021
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders